NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT
https://doi.org/10.21292/2078-5658-2015-12-3-48-55
Abstract
The major heart attack in the carotid system, going with the cerebral edema is considered to date as the most mortal type of the ischemic stroke. The only prove successful treatment policy is the decompressive craniectomy. The early start of the operative intervention, reported in the references, brings about improvement of the clinical outcomes, however under limited time the diagnostics issues remain open and, as a consequence there perform the unreasonable traumatic operational assistance. 43 patients with the severe ischemic stroke were examined and an analysis of the S100-b glial peptide as a marker of malignant brain infarction course was performed. The neuropeptide monitoring in the blood serum allows detection of the responders to the decompressive craniectomy among the high-risk patients within 12-16 hours of the disease onset till the clinical deterioration development, when according to the computerized tomography the certain changes have not in yet.
About the Authors
T. Yu. Shaytanova
E. E. Volosevich First Municipal Clinical Hospital, Arkhangelsk
Russian Federation
Russian Federation
V. A. Saskin
E. E. Volosevich First Municipal Clinical Hospital, Arkhangelsk
Russian Federation
Russian Federation
E. V. Nedashkovsky
Northern State Medical University, Arkhangelsk
Russian Federation
Russian Federation
References
1. Skvortsova V.I. et al. Tromboliticheskaya terapiya pri ishemicheskom insulte: metod. posob. [Thrombolytic therapy for ischemic attack. Guidelines]. Moscow, 2011. 48 p.
2. Shaytanova T.Yu., Saskin V.A., Nedashkovsky E.V. Practical use of S-100B protein in acute cerebrovascular pathology. Vestnik Anasteziol. i Reanimatol., 2014, no. 2, pp. 63-71. (In Russ.)
3. Cho D., Chen T., Lee H. Ultra-early decompressivecraniectomy for malignant middle cerebral artery infarction. Surg. Neurol., 2003, vol. 60, pp. 227-232.
4. Hacke W., Schwab S., Horn M. et al. Malignant middle cerebral artery territory infarction: clinical course and prognostic signs. Arch. Neurology, 1996, vol. 53, pp. 309-315.
5. Haring H.-P., Dilitz E., Pallua A. et al. Attenuated corticomedullary contrast: an early cerebral computed tomography sign indicating malignant middle cerebral artery infarction. А case-control study. Stroke, 1999, vol. 30, pp. 1076-1082.
6. Jauch E.C., Lindsell C., Broderick J. et al. Association of serial biochemical markers with acute ischemic stroke: the national institute of neurological disorders and stroke recombinant tissue plasminogen activator stroke study. Stroke, 2006, vol. 37, no. 10, pp. 2508-2513.
7. Jauch E.C., Saver J.L., Adams H.P. et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association. Stroke, 2013, vol. 44, pp. 870-947.
8. Minnerup J., Wersching H., Ringelstein E.B. et al. Prediction of malignant middle cerebral artery infarction using computed tomography-based intracranial volume reserve measurements. Stroke, 2011, vol. 42, no. 12, pp. 3403-3409.
9. Nash D.L., Bellolio M.F., Stead L.G. S100 as a marker of acute brain ischemia: a systematic review. Neurocrit. Care, 2008, vol. 8, no. 2, pp. 301-307.
10. Oppenheim C., Samson Y., Manai R. et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke, 2000, vol. 31, pp. 2175-2181.
11. Rahme R. Zuccarello M., Kleindorferet D. et al. How often are patients with ischemic stroke eligible for decompressivehemicraniectomy? Stroke, 2012, vol. 43, pp. 550-552.
12. Ropper A.H., Shafran B. Brain edema after stroke: clinical syndrome and intracranial pressure. Arch. Neurol., 1984, vol. 41, no. 1, pp. 26-29.
13. Vahedi K., Hofmeijer I., Juettler E. et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomized controlled trials. Lancet Neurol., 2007, vol. 6, no. 3, pp. 215-222.
14. Wijdicks E.F., Sheth K.N., Carter B.S. et al Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the american heart association. Stroke, 2014, vol. 45, no. 4, pp. 1222-1238.
Review
For citations:
Shaytanova T.Yu., Saskin V.A., Nedashkovsky E.V. NEUROPEPTIDE S100-b: THE DIAGNOSIS OF A MALIGNANT CEREBROVASCULAR ACCIDENT. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2015;12(3):48-55. (In Russ.) https://doi.org/10.21292/2078-5658-2015-12-3-48-55
Email this article 